Literature DB >> 8526595

Disparate effects of nitric oxide on lung ischemia-reperfusion injury.

M J Eppinger1, P A Ward, M L Jones, S F Bolling, G M Deeb.   

Abstract

BACKGROUND: Inhaled nitric oxide (.NO) has been found to be a potent pulmonary vasodilator. We assessed whether .NO, through this function or others, could alleviate lung reperfusion injury.
METHODS: Rats underwent thoracotomy, with clamps used to create left lung ischemia. After 90 minutes of ischemia, clamps were released, permitting reperfusion for either 30 minutes or 4 hours. Additional animals received inhaled .NO via the ventilator to determine its effects on reperfusion injury.
RESULTS: Lung injury, measured by increased vascular permeability using iodine-125-labeled bovine serum albumin leakage, was significantly increased in ischemic-reperfused animals compared with time-matched shams not undergoing ischemia. Inhaled .NO delivered at the start of reperfusion worsened injury at 30 minutes but was protective at 4 hours. The increased injury could be avoided either by delaying .NO for 10 minutes or by treating the animals with superoxide dismutase before reperfusion. .NO reversed postischemic pulmonary hypoperfusion at 4 hours, as measured by labeled microspheres. Lung neutrophil content was significantly reduced at 4 hours in .NO-treated animals.
CONCLUSIONS: .NO is toxic early in reperfusion, due to its interaction with superoxide, but is protective at 4 hours of reperfusion, due to reversal of postischemic lung hypoperfusion and reduction of lung neutrophil sequestration.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8526595     DOI: 10.1016/0003-4975(95)00697-J

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  10 in total

1.  Mediators of ischemia-reperfusion injury of rat lung.

Authors:  M J Eppinger; G M Deeb; S F Bolling; P A Ward
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

Review 2.  Inhaled pulmonary vasodilators: a narrative review.

Authors:  Kai Liu; Huan Wang; Shen-Ji Yu; Guo-Wei Tu; Zhe Luo
Journal:  Ann Transl Med       Date:  2021-04

3.  A spontaneous nitric oxide donor ameliorates small bowel ischemia-reperfusion injury in dogs.

Authors:  K Kawata; I Takeyoshi; K Iwanami; Y Sunose; M Aiba; S Ohwada; K Matsumoto; Y Morishita
Journal:  Dig Dis Sci       Date:  2001-08       Impact factor: 3.199

4.  Preventive influence of inhaled nitric oxide on lung ischemia-reperfusion injury.

Authors:  H Yamagishi; C Yamashita; M Okada
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

5.  Necrostatin-1 Synergizes the Pan Caspase Inhibitor to Attenuate Lung Injury Induced by Ischemia Reperfusion in Rats.

Authors:  Liangrong Wang; Baihui Chen; Xiangqing Xiong; Shunli Chen; Lida Jin; Meizhen Zhu
Journal:  Mediators Inflamm       Date:  2020-10-24       Impact factor: 4.711

6.  Coronary Bypass Surgery in Patients with Pulmonary Hypertension: Assessment of Early and Long Term Results.

Authors:  Baris Akca; Nevzat Erdil; Olcay Murat Disli; Koksal Donmez; Feray Erdil; Mehmet Cengiz Colak; Bektas Battaloglu
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-03-09       Impact factor: 1.520

Review 7.  Inflammatory response to pulmonary ischemia-reperfusion injury.

Authors:  Calvin S H Ng; Song Wan; Ahmed A Arifi; Anthony P C Yim
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

Review 8.  Lung ischemia-reperfusion injury: implications of oxidative stress and platelet-arteriolar wall interactions.

Authors:  Alexander V Ovechkin; David Lominadze; Kara C Sedoris; Tonya W Robinson; Suresh C Tyagi; Andrew M Roberts
Journal:  Arch Physiol Biochem       Date:  2007-02       Impact factor: 4.076

9.  Length of pressure-controlled reperfusion is critical for reducing ischaemia-reperfusion injury in an isolated rabbit lung model.

Authors:  Stefan Guth; Diethard Prüfer; Thorsten Kramm; Eckhard Mayer
Journal:  J Cardiothorac Surg       Date:  2007-12-07       Impact factor: 1.637

Review 10.  Pulmonary Protection Strategies in Cardiac Surgery: Are We Making Any Progress?

Authors:  Emad Al Jaaly; Mustafa Zakkar; Francesca Fiorentino; Gianni D Angelini
Journal:  Oxid Med Cell Longev       Date:  2015-10-20       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.